Results 261 to 270 of about 138,761 (339)

Gastroenteropancreatic Neuroendocrine Neoplasms and Celiac Disease: Rare or Neglected Association? [PDF]

J Clin Med
Pes L, La Salvia A, Pes GM, Dore MP, Fanciulli G.   +4 more
europepmc   +1 more source

Letter: Supporting the Role of Enzyme Therapy in Management of Coeliac Disease—Authors' Reply

Alimentary Pharmacology &Therapeutics, EarlyView.
Erin R. Bonner, Werner Tschollar, Robert Anderson, Sulayman Mourabit   +3 more
wiley   +1 more source

Establishing the performance and acceptability of dried blood spot sampling to screen for islet‐specific autoantibodies

Diabetic Medicine, EarlyView.
This comprehensive validation and acceptability study shows dried blood spot sampling can be used as an alternative to serum for use with the 3‐screen assay for population type 1 diabetes autoantibody screening and appears acceptable to parents and stakeholders.
Siân E. Faustini, Lauren M. Quinn, Madeeha Hoque, Siobhan Young, Christopher Bentley, Hin‐Fai Kwok, Timothy Plant, Ian Litchfield, Felicity Boardman, Sheila M. Greenfield, Parth Narendran, Alex G. Richter   +11 more
wiley   +1 more source

AGA vs AEA IN THE MASS SCREENING OF CELIAC DISEASE: PRELIMINARY RESULTS OF THE SARDINIA STUDY

, 1998
Carlo Catassi, Giuseppe Fanciulli, A Villari, Barbara Bruschi, Ramzi El Asmar, L De Luna, Marco Cossu, E Fabiani, I. Bearzi, G V Coppa   +9 more
openalex   +1 more source

Celiac Disease: Beyond Diet and Food Awareness. [PDF]

Foods
Herrera-Quintana L, Navajas-Porras B, Vázquez-Lorente H, Hinojosa-Nogueira D, Corrales-Borrego FJ, Lopez-Garzon M, Plaza-Diaz J.   +6 more
europepmc   +1 more source

Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes

Diabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2495-2506, May 2025.
Abstract Aims This study surveyed individuals and caregivers of children who received teplizumab at stage 2 type 1 diabetes (T1D) to garner real‐world experiences and their health outlook for the future following treatment with the first approved disease‐modifying immune therapy for delaying the onset of Stage 3 T1D.
Holly K. O'Donnell, Kimber M. Simmons, Stephen E. Gitelman, Terry Dex, Robert Hill, Mattias Wieloch, Julia Zaccai, Jennifer D'Souza, France Ginchereau Sowell, James Turnbull, Korey K. Hood   +10 more
wiley   +1 more source

DYSPEPSIA AND GERD COMPLAINTS AS PRESENTING SYMPTOMS OF CELIAC DISEASE IN PREADOLESCENTS

, 1998
J Kelly
openalex   +1 more source

Celiac Disease: A Transitional Point of View. [PDF]

Nutrients
Aitella E, Cozzolino D, Ginaldi L, Romano C.   +3 more
europepmc   +1 more source

Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screening

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Type 1 diabetes is recognized as a chronic disease with a presymptomatic phase that does not require insulin therapy and a clinical phase where insulin treatment becomes necessary. The presymptomatic phase is characterized by the presence of autoantibodies targeting pancreatic islet beta cell antigens (islet autoantibodies).
Ezio Bonifacio, Anette‐Gabriele Ziegler   +1 more
wiley   +1 more source

HLA TYPING AND RESULTS OF LINKAGE ANALYSIS TO CHROMOSOME 6p IN 72 KINDRED WITH CELIAC DISEASE

, 1998
Linda Book, Susan L. Neuhausen, Lisa Cannon‐Albright, J. W. Black, Cathryn M. Lewis, John J. Zone   +5 more
openalex   +1 more source